NMRA vs SNA · $283.5M cap vs P/E 17, rev $5.11B
Neumora Therapeutics, Inc. (NMRA) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported SNA revenue for 2024-12-28 was $5.11B. Net income was $1.07B. Revenue was up 0.0% from 2023-12-30 to 2024-12-28. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
NMRA currently screens at market cap $283.5M. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the NMRA and SNA stock pages for the full models.
Not investment advice.